Merck Keeps Pharma M&A Flowing With $9.5B Cubist Pickup
Merck & Co. Inc. said Monday it would absorb Cubist Pharmaceuticals in a deal worth $9.5 billion including debt, its second big-ticket acquisition this year and its first foray into treatments...To view the full article, register now.
Already a subscriber? Click here to view full article